Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer

被引：0
|
作者：
Hwang, W. Y. [1 ]
Kim, S. I. [2 ]
Lee, M. [2 ]
Kim, K. [1 ]
No, J. H. [1 ]
Kim, J. W. [2 ]
Kim, Y. B. [1 ]
Suh, D. H. [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
756
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [1] THE IMPACT OF ADVANCED CHEMOTHERAPY LINES ON SURVIVAL IN RECURRENT EPITHELIAL OVARIAN CANCER: SINGLE CENTRE EXPERIENCE
    Villa, Michela
    Badellino, Enrico
    Pace, Luca
    Massobrio, Roberta
    Attianese, Daniela
    Giorgi, Margherita
    Ferrero, Annamaria
    Biglia, Nicoletta
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A298 - A299
  • [2] Impact of obesity on treatment and survival outcome in epithelial ovarian cancer patient
    Sompohnmanas, Asavarak
    Achariyapota, Vuthinun
    Pooliam, Julaporn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A194 - A195
  • [3] IMPACT OF CHEMOTHERAPY BEYOND THE THIRD LINE IN PATIENTS WITH RECURRENT EPITHELIAL OVARIAN CANCER
    Mansi, L.
    Kalbacher, E.
    Demarchi, M.
    Bazan, F.
    Schneider, M.
    Vuillemin, A.
    Bernhard, S.
    Nerich, V.
    Borg, C.
    Pivot, X.
    ANNALS OF ONCOLOGY, 2012, 23 : 332 - 332
  • [4] Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer
    Mansi, Laura
    Demarchi, Martin
    Bazan, Fernando
    Delroeux, Delphine
    Chaigneau, Loic
    Thiery-Vuillemin, Antoine
    Bernhard, Sandrine
    Lakkis, Zaehr
    Nerich, Virginie
    Pivot, Xavier
    Kalbacher, Elsa
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (02) : 261 - 267
  • [5] Survival impact of neoadjuvant and adjuvant chemotherapy cycles stratified by interval debulking surgical approach in advanced epithelial ovarian cancer
    Zhang, Y.
    Grant, M. S.
    Paraghamian, S. E.
    Clark, L. H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 153 - 154
  • [6] The impact of age on comorbidity, toxicity of chemotherapy and survival in recurrent ovarian cancer patients
    Woopen, H.
    Inci, G.
    Richter, R.
    Chekerov, R.
    Sehouli, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 101 - 101
  • [7] Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
    Chen, Wei-Chun
    Huang, Huei-Jean
    Yang, Lan-Yan
    Pan, Yu-Bin
    Huang, Kuan-Gen
    Lin, Cheng-Tao
    Chen, Min-Yu
    Tang, Yun-Hsin
    Chang, Ting-Chang
    Lai, Chyong-Huey
    Chou, Hung-Hsueh
    BIOMEDICAL JOURNAL, 2022, 45 (05) : 821 - 827
  • [8] Outcome following Hyperthermic Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer, the first Egyptian Experience
    Gareer, W. Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S540 - S540
  • [9] Impact of neoadjuvant chemotherapy cycles prior to interval surgery in patients with advanced epithelial ovarian cancer
    Colombo, P. E.
    Labaki, M.
    Fabbro, M.
    Bertrand, M.
    Mourregot, A.
    Gutowski, M.
    Saint-Aubert, B.
    Quenet, F.
    Rouanet, P.
    Mollevi, C.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 223 - 230
  • [10] Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis
    Keskin, Serkan
    Kucucuk, Seden
    Ak, Naziye
    Atalar, Banu
    Sari, Murat
    Sozen, Hamdullah
    Ibis, Kamuran
    Topuz, Samet
    Saip, Pinar
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 101 - 105
12345